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Introduction
The number of live endoscopy events (LEE) has increased con-
siderably over the last 20 years, and in most cases, they provide
an excellent opportunity for physicians and nurses to witness
state-of-the-art endoscopic procedures as well as new and in-
novative developments. However, a number of ethical and pa-
tient-related issues have been raised, especially concerning
complications, patient outcome as well as success rate. Various
factors could have a negative influence on the outcome of pro-
cedures during LEE, including the fact that the operator has to
concentrate on teaching and treatment simultaneously. Also,
communication difficulties between the operator and the host
staff as well as the stress of performing in front of a live audi-
ence could influence performance of the examiner [1]. Publica-
tions on endoscopic retrograde cholangiopancreatography
(ERCP) during LEE have shown similar complication and success
rates compared to routine procedures [1–3].
These issues prompted the European Society of Gastrointes-
tinal Endoscopy (ESGE) to release a position statement on live
endoscopy events in which it is stated that the primary utility
of LEE is the educational value for the audience, and patients
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ABSTRACT
Background and study aims There are no data showing
the outcome of ESD during live endoscopy events (LEE).
ESD performed during the Augsburg Endo-Update LEE
were compared with matched routine procedures with the
aim of demonstrating non-inferiority of LEE ESD.
Patients and methods ESD performed during the Endo-
Update between 2006 and 2018 were reviewed. The con-
trols were routine procedures matched according to age,
location and lesion size. Resection, recurrence, survival
and complication rates, procedure time and propofol seda-
tion were assessed. Clinically relevant margins were as-
sumed for resection and complication rates, procedure
time and propofol sedation quantity.
Results Thirty-eight ESD were performed in the given time
period, and were compared with 38 matched routine ESD.
En bloc and curative resection rates in the LEE group and in
the control group were 100% and 87% as well as 84% and
71% respectively, while procedure times were 135 and 125
minutes, respectively. Non-inferiority was demonstrated
for resection rates and procedure time. The complication
rate was lower in the LEE group as compared with the con-
trol group (5% vs 13%) while propofol sedation was similar
in both groups (863mg vs 872mg). Recurrence and 5-year
survival rates for both groups were 4% vs 0% and 70% vs
65% respectively.
Conclusions The resection rate and procedure time of ESD
during LEE was non-inferior to those of routine ESD proce-
dures. Comparison of the complication rates, however,
was inconclusive owing to the low patient number and
complication risk in both groups.
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should not expect an additional benefit of being treated during
a LEE compared to a routine setting [4].
An important aspect of LEE is that challenging procedures
are often chosen for demonstration. The reason for this may
be to educate physicians witnessing the LEE or also that experts
especially proficient in these procedures are available during
the LEE. One such procedure is endoscopic submucosal dissec-
tion (ESD) of early gastrointestinal lesions. ESD, developed in
Japan, is an extremely tedious and difficult to learn endoscopic
procedure with a long learning curve. There are no data or evi-
dence showing the outcome of ESD during LEE.
In this paper, we present a retrospective match-controlled
study comparing the outcome of ESD patients of the Universi-
tätsklinikum Augsburg (UKA) treated during the live endoscopy
event, Endo-Update, from 2006 to 2018. The primary aim of
the study was to determine the success rate and safety of ESD
during LEE.
Endo-Update is held annually and was initiated in 2006 with
the primary aim of demonstrating novel and innovative endo-
scopic interventions in a real-life setting. Endoscopic cases at
the Endo-Update are treated by world-class experts, and lesions
are chosen especially for educational purposes. Procedures are
shown via satellite to about 1000 observing physician-gastro-
enterologists. Because of the availability of experts during
Endo-Update, cases selected for demonstration often tend to
be more challenging and demanding. However, emphasis is
placed on demonstrating technical and educational aspects of
each procedure.
The UKA is a high-volume ESD center with an annual case
load of about 200 ESD procedures performed by three endos-
copists. The first ESD procedure in the UKA was conducted in
2003.
Patients and methods
All patients treated with ESD (n=38) during Endo-Update were
included in the study. The control group (n =38) were patients
treated during the same period in the endoscopy unit of the
UKA by local endoscopists. Similar to the methodology adop-
ted by Schmit et al, ESD cases performed after each Endo-Up-
date were evaluated chronologically until the first best match
was identified [1]. This patient was then included in the control
group. This procedure was conducted for all Endo-Update pa-
tients (LEE group) during the period from 2006 to 2018. The
control group was matched with the LEE group according to
age of patients, size and location of lesions (▶Table 1). Lesion
size was broken into three categories: 0 to 2 cm, 2 to 4 cm and
larger than 4 cm. Lesions larger than 4 cm were matched with
lesions that were ±1 cm larger or smaller. No recurrent lesions
were included in the LEE group, which meant that this was not a
matching criterion. All patients had an American Society of An-
esthesiology (ASA) score of I or II.
Rates of en-bloc and curative resection, survival, recurrence,
and complications, and examination time and quantity of pro-
pofol sedation were evaluated and compared between both
groups using a clinically relevant, non-inferiority margin.
En-bloc resection was defined as complete resection of the
tumor or lesion in one piece.
Curative resection was defined as tumor-free lateral and ver-
tical margins, without lymphatic or vascular involvement and a
maximum submucosal invasion depth of≤1000µm for the col-
orectum and ≤500µm for gastric and esophageal adenocarci-
noma while squamous cell carcinoma of the esophagus was
limited to the upper (m1) or middle (m2) mucosal layer [5, 6].
Complications and adverse events (AE) were defined accord-
ing to a lexicon of AE described by Cotton et al [7]. These in-
cluded not just complications directly linked to the ESD inter-
vention, such as perforation, but also others associated with se-
dation or anesthesia. Postinterventional bleeding was defined
as presence of hematemesis and/or melena or a drop in the he-
▶ Table 1 Matched parameters for both study groups.
LEE (n=38) Control (n=38)
Age (years) Mean: 67 (range 24–84) Mean: 65 (range 28–89)
Sex (female/male) 9/29 13/25
Location Esophagus/esophagogastric junction (n =11, 29%) Esophagus/esophagogastric junction (n = 11, 29%)
Stomach (n =10, 26%) Stomach (n = 10, 26%)
Kolon (n =4, 11%) Kolon (n =4, 11%)
Sigma (n =2, 5%) Sigma (n =2, 5%)
Rectum (n=11, 29%) Rectum (n=11, 29%)
Size 1–2 cm (n =1, 3%) 1–2 cm (n=1, 3%)
2–4 cm (n =14, 37%) 2–4 cm (n=14, 37%)
> 4 cm (n=23, 60%) > 4 cm (n =23, 60%)
LEE, live endoscopy event
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moglobin level of > 2g/dL which led to re-endoscopy for bleed-
ing control.
Examination time was defined as time from insertion of the
endoscope to completion of resection.
The quantity of propofol was measured in milligrams. Propo-
fol sedation was measured only for patients receiving deep in-
tra-venous sedation.
A recurrence was defined as discovery of a new lesion during
a surveillance endoscopy at the same location where the pre-
vious ESD was performed.
The overall survival rate was stated as a 5-year survival rate,
which was the percentage of the patients, who were alive 5
years after ESD treatment.
Confidence intervals for differences between the study
groups were computed with NCSS Statistical Software 2019. A
clinically relevant effect for the study parameters was defined
as follows: a difference in examination time of at least 60 min-
utes, a difference in propofol sedation quantity of at least
200mg, a difference in curative or en bloc resection rate of 5%
and a difference in complication rate of 5%. Non-inferiority was
achieved when the confidence intervals excluded the clinically
relevant effect. As such, non-inferiority margins were+60 (pro-
cedure time), + 200 (propofol sedation), –5 (resection rate) and
+5 (complication rate). Non-inferiority margins were chosen as
above because it was assumed that for LEE, cases tended to be
more challenging and also endoscopists had to explain their
procedures to the audience during LEE which would be more
time-consuming. It was assumed that a margin of 60 minutes,
1 ampoule of propofol (200mg) or a difference of 5% in resec-
tion and complication rate was acceptable.
The learning curve of local ESD endoscopists over the 13-
year study period was also taken into consideration by dividing
the study period into two halves. The first half included proce-
dures performed from 2006 to 2012 while the second half was
from 2013 to 2018. For this subgroup analysis, computation of
confidence intervals was not done due to the low patient num-
ber.
Results
Thirty-eight ESD procedures were performed between 2006
and 2018 during the Augsburg Endo-Update LEE. Thirty-eight
ESD procedures done outside the LEE (control group) were mat-
ched using the parameters described above (▶Table 1). All 38
ESDs in the control group were performed by local endos-
copists. In the LEE group, 82% (n=31) of ESD procedures were
done by Japanese ESD experts while 18% (n=7) were done by
two local endoscopists. In the first half of the study period
(2006 to 2012), 20 ESD procedures were performed while 18
ESD procedures were conducted in the second half (2013 to
2018).
En bloc resection was achieved in 100% (n=38) in the LEE
group and in 87% (n=33) in the control group. The clinically rel-
evant effect and the non-inferiority margin were below the low-
er limit of the confidence intervals (▶Table 2).
The overall curative resection rate was 84% (n=32) in the
LEE group and 71% (n=27) in the control group. The clinically
relevant effect and the non-inferiority margin were at the lower
limit of the confidence intervals (▶Table 2).
Two patients (5%) in the LEE group and five patients (13%) in
the control group experienced a complication (▶Table 2). Two
patients (5%) in the LEE group and 3 patients (8%) in the con-
trol group had postinterventional bleeding with need for re-
endoscopy for bleeding control. No patients (0%) in the LEE
group and one patient (3%) in the control group experienced a
perforation in the upper colon that led to surgery. One patient
▶ Table 2 Comparison of resection rates, procedure time, propofol sedation and complication rate between the LEE group and the matched-control
group.
LEE; n=38 Control; n =38 Difference (95%-CI)
En bloc resection 100%; (38/38) 87%; (33/38) 13% (2.5, 27.8)
Curative resection 84%; (32/38) 71%; (27/38) 13% (–6.1, 32.1)
Procedure time 10 (–19.6, 39.6)
▪ Mean (min) 135 125
▪ Range (min) 40–210 50–375
Propofol sedation 9 (–313.7, 295.7)
▪ Mean (mg) 863 872
▪ Range (mg) 120–2000 100–2150
Complication 5%; (2/38) 13%; (5/38) 8% (–20.8, 5.0)
Bleeding 2 (5%) 3 (8%)
Perforation 0 (0%) 1 (3%)
NSTEMI 0 (0%) 1 (3%)
LEE, live endoscopy event; NSTEMI, non-ST segment myocardial infarction
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(3%) in the control group developed a myocardial infarction
(non-ST segment elevation MI [NSTEMI]) within 48 hours after
the endoscopic procedure. No other complications were ob-
served. The clinically relevant effect and the non-inferiority
margin were within the confidence intervals (▶Table2).
Median procedure time between the LEE group (135 min-
utes) and the control group (125 minutes) was similar. The
clinically relevant effect and the non-inferiority margin were
excluded by the confidence intervals (▶Table 2).
Propofol sedation was used in 55% of interventions (n =21)
in the LEE group and 71% (n=27) in the control group.Mean
values of 863 and 827mg of propofol were used in the LEE
group and the control group, respectively. The quantity of pro-
pofol per minutes was 6.4mg/min in the LEE group and 7.0mg/
min in the control group. The clinically relevant effect and the
non-inferiority margin were within the confidence intervals
(▶Table 2).
Surveillance endoscopies were performed after 6 and 18
months. Of the patients in the LEE group, 96% (n=26/27)
were recurrence-free after 6 months and 95% (n=20/21) after
18 months (▶Table 3). Unfortunately, 29% of the patients (n =
11/38) were lost to follow-up after 6 months and 50% (n=17/
34) after 18 months in the LEE group. Four patients are still
awaiting the 18-month surveillance.
In the control group, 100% of patients (n =24/24) were re-
currence-free after 6 months and 100% (n=19/19) after 18
months. Of the patients, 37% (n=14/38) were lost to follow-
up after 6 months and 56% (n=19/34) after 18 months. Four
patients are still awaiting the 18-month surveillance. There
was no documented recurrence in the control group.
Retrospective information as regards the 5-year survival rate
(▶Table 3) was available for 23 of 38 patients in each group. In
the LEE group, the 5-year survival rate was 70% (n=16/23)
while in the control group the 5-year survival rate was 65% (n
=15/23).
Of the patients in the LEE group, 13% (n=3/23) died within 5
years after the intervention. Cause of death was not related to
ESD or to disease for which ESD was performed.
In the control group, three patients died within 5 years, two
of them not related to the disease for which ESD was per-
formed. One patient died of metastatic esophageal carcinoma
after initially curative intended ESD followed by radiochemo-
therapy 24 months after ESD-intervention. Four patients in the
LEE group and five patients in the control group were lost to fol-
low-up.
Twenty procedures (53%) were conducted from 2006 to
2012 and 18 procedures from 2013 to 2018 (47%) in both
groups (▶Table4). Curative resection rates improved from the
first study period to the second study period (60% vs 75% in the
control group and 83% vs 94% in the LEE group).
The complication rate during the first study period (2006 to
2012) was lower in the LEE group than in the control group (5%
vs 15%) with three cases of postinterventional bleeding in the
control group (15%) and one case of bleeding in the LEE group
(5%). In the second study period, the complication rate was 6%
(1× bleeding) in the LEE group and 11% (1× perforation, 1×
NSTEMI) in the control group.
Discussion
This is the first report showing the outcome of ESD procedures
during a live endoscopy event (LEE). Various publications have
shown that ERCP can be done safely and successfully, however,
there are no data on ESD during a LEE. ESD is a tedious and dif-
ficult-to-learn procedure that originated in Japan and gradually
spread to Europe and other Western regions [8, 9].
ESD requires a high level of proficiency and skill, and the
question about whether such an advanced and challenging pro-
cedure can be safely demonstrated at a LEE is important, espe-
cially considering the growing number of LEE. In ESD, the com-
plex interplay between the operator and assistance personnel is
crucial for a successful outcome. During LEE, the understanding
between a foreign operator and the home personnel may be
hindered, for example, by language barriers.
In our retrospective match-control study, we have shown
that ESD procedures carried out during Endo-Update were
non-inferior to those performed on routine controls in terms
of resection rates and procedure time. The definition of a clini-
cally relevant effect in a retrospective study design may appear
arbitrary or even biased towards non-inferiority. However, the
margins chosen for this study were based on statistical reason-
ing as well as clinical judgement. Non-inferiority was also
shown for procedure time between the Endo-Update and con-
trol groups. The explanation may be that although the experts
performing the ESD during Endo-Update may have spent more
time lecturing to the audience or even waiting to demonstrate
interesting aspects of a given procedure, they were still able to
make up for this “lost time” due to their high level of skill and
proficiency. Recurrence and overall 5-year survival rates were
similar in both groups, however, owing to the low patient num-
ber, confidence intervals were not computed for these param-
eters.
Verbal and non-verbal communication necessary for a suc-
cessful ESD did not seem to have a relevant effect on the per-
formance of the foreign operators. A possible explanation for
this may be the high level of expertise and proficiency of the
foreign operators as well as the training and education of the
assistance personnel. Furthermore, foreign operators were
able to influence the choice of lesions and had sufficient time
to assess their cases before the Endo-Update. Pre-intervention-
al preparation took place together with the home team and in-
volved clear communication on choice of equipment, electro-
▶ Table 3 Comparison of recurrence and survival rates between the
study groups.
Recurrence LEE Control
After 6 months 4% (1/27) 0% (0/27)
After 18 months 6% (1/17) 0% (0/17)
5-year survival rate LEE n=23 Control n =23
70% (16/23) 65% (15/23)
LEE, live endoscopy event
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surgical settings, ESD resection strategy, and risk management
plan in case of an AE such as bleeding or perforation. Finally, Ja-
panese operators were often accompanied by a second physi-
cian who supervised the assistance personnel before, during
and after the ESD procedures. These points may have influ-
enced the smoothness of the ESD procedures and also had an
educational benefit for the home team.
Over the course of time, local endoscopists improved their
level of proficiency with improved resection and complication
rates (▶Table 4). Again, due to the low patient number in the
subgroup, confidence intervals were not computed but at least
the tendency can be appreciated. In a recent meta-analysis, it
was shown that the level of proficiency in ESD remains higher
in Asian countries as compared to the West [10]. However, it
also seems to be that ESD endoscopists in the West have im-
proved their skills considerably in the past decade. Could this
improvement be attributed, also, to LEE? The European Society
of Gastrointestinal Endoscopy (ESGE) position statement on live
endoscopy events states that the primary utility of LEE is the
educational value [4]. The educational benefits of LEE are diffi-
cult to quantify from the data shown here. At least, there may
have been an additional educational benefit for the local ex-
perts and their endoscopy assistance because all procedures
performed by Japanese experts during the Endo-Update were
accompanied by the local staff of the hospital.
A major limitation of this study is the low patient number as
well as the retrospective nature of the study. A higher number
of patients would have narrowed the confidence intervals,
thereby improving the statistical power of the study. This was
obvious in the study parameters (propofol sedation and compli-
cation rate) in which the confidence intervals were not able to
exclude the clinically relevant effects, thus making a compari-
son of these study outcomes inconclusive. In a prospective ap-
proach, other aspects of LEE, especially time spent on waiting
“to go on-air,” could have been assessed. Also, a more accurate
match-control using other parameters such as morphology and
accessibility (SMSA classification) could have been achieved
[11]. Also, it was not possible to evaluate the amount of addi-
tional sedatives, such as midazolam or opiates, given to pa-
tients receiving propofol sedation. The fact that the majority
of the ESD procedures during the Endo-Update were per-
formed by Japanese experts is a bias in itself, and may lead to a
question about whether the same results would hold for local
endoscopists performing ESD during a LEE. The excellent out-
comes of the en bloc resection rates with a tendency towards
statistical significance underscore the expertise of the endos-
copists who performed the ESD procedures in the LEE group in
this study. From this study, it is obvious that whoever is chosen
to perform an ESD during a LEE must have a high level of profi-
ciency, confidence and experience.
Conclusion
Based on the data from this study, we can rightfully conclude
that ESD procedures performed during LEE are non-inferior to
routine procedures in terms of resection rate and procedure
time. This may have an impact on endoscopy society guidelines
around LEEs, and is also an important point for informed con-
sent of patients undergoing an ESD during a LEE. However, a
higher number of patients needs to be assessed, if possible, in
a multicenter approach, to guarantee sufficient statistical pow-
er to make a conclusion on other study outcomes including
complication rates.
▶ Table 4 Comparison of resection rates, procedure time, propofol sedation, and complication rates between study groups during the two study
periods.
2006–2012 (n=20) 2013–2018 (n=18)
LEE Control Difference LEE Control Difference
En bloc resection 100% (20/20) 90% (18/20) 10% 100% (18/18) 83% (15/18) 7%
Curative resection 75% (15/20) 60% (12/20) 15% 94% (17/18) 83% (15/18) 11%
Complication 5% (1/20) 15% (3/20) 10% 6% (1/18) 11% (2/18) 5%
Bleeding 5% (1/20) 15% (3/20) 6% (1/18) 0% (0/18)
Perforation 0% (0/20) 0% (0/20) 0% (0/18) 6% (1/18)
NSTEMI 0% (0/20) 0% (0/20) 0% (0/18) 6% (1/18)
Procedure time
▪ Mean (min) 129 134 5 140 119 21
▪ Range (min) 75–195 80–225 40–210 50–375
Propofol sedation
▪ Mean (mg) 837 839 2 892 913 21
▪ Range (mg) 350–2000 120–2150 120–1920 100–1300
LEE, live endoscopy events; NSTEMI, non-ST segment elevation myocardial infarction
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